Symphony Capital Partners LP's Net Worth

$96.6 Million

Estimate Recalculated Nov 1, 2024 10:35AM EST

Who is Symphony Capital Partners LP

Symphony Capital Partners LP has an estimated net worth of $96.6 Million. This is based on reported shares across multiple companies, which include DYNAVAX TECHNOLOGIES CORP, Alexza Pharmaceuticals Inc., and OXIGENE INC.

SEC CIK

Symphony Capital Partners LP's CIK is 0001296059

Past Insider Trading and Trends

2010 was Symphony Capital Partners LP's most active year for acquiring shares with 2 total transactions. Symphony Capital Partners LP's most active month to acquire stocks was the month of March. 2010 was Symphony Capital Partners LP's most active year for disposing of shares, totalling 1 transactions. Symphony Capital Partners LP's most active month to dispose stocks was the month of March. 2010 saw Symphony Capital Partners LP paying a total of $0.00 for 9,722,065 shares, this is the most they've acquired in one year. In 2010 Symphony Capital Partners LP cashed out on 1,283,200 shares for a total of $0.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Alexza Pharmaceuticals Inc.

Investor
Updated Sep 08, 2009
Form 3
Sep 08, 2009
6.72M
Showing 1 results

DYNAVAX TECHNOLOGIES CORP

Investor
Updated Apr 20, 2010
Form 4
87.69%
8.44M
Apr 20, 2010
18.06M
Acquisition
Apr 16
Form 3
Jan 11, 2010
8.34M
Showing 2 results

OXIGENE INC

Investor
Updated Aug 12, 2009
Form 4
58.42%
10.00M
Aug 12, 2009
27.12M
Acquisition
Jul 20
Form 4
$1.11
$12.52M
Aug 12, 2009
17.12M
Options
Dec 30
Form 3
Aug 12, 2009
5.84M
Showing 3 results